Cambridge Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cambridge Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$529K	Buy	12,576 +3,283	+35%	+$105K	0.09%	122
2026 Q1	$246K	Buy	9,293 +1,031	+12%	+$30.2K	0.05%	164
2025 Q4	$239K	Buy	+8,262	New	+$248K	0.05%	167
2022 Q2	–	Sell	-22,617	Closed	-$1.04M	–	178
2022 Q1	$1.04M	Buy	22,617 +400	+2%	+$19.1K	0.25%	65
2021 Q4	$1.36M	Sell	22,217 -698	-3%	-$48.3K	0.31%	57
2021 Q3	$1.71M	Buy	22,915 +386	+2%	+$32.4K	0.42%	35
2021 Q2	$2.08M	Buy	22,529 +4,278	+23%	+$364K	0.5%	30
2021 Q1	$1.62M	Buy	18,251 +2,902	+19%	+$288K	0.41%	40
2020 Q4	$1.43M	Buy	15,349 +903	+6%	+$71.9K	0.39%	43
2020 Q3	$920K	Buy	14,446 +730	+5%	+$42.8K	0.27%	65
2020 Q2	$715K	Buy	13,716 +1,648	+14%	+$70.7K	0.22%	74
2020 Q1	$377K	Sell	12,068 -6,558	-35%	-$219K	0.14%	95
2019 Q4	$624K	Sell	18,626 -282	-1%	-$8.96K	0.19%	83
2019 Q3	$558K	Buy	18,908 +225	+1%	+$7.31K	0.18%	78
2019 Q2	$644K	Buy	18,683 +408	+2%	+$13.1K	0.21%	78
2019 Q1	$601K	Sell	18,275 -500	-3%	-$14.8K	0.2%	81
2018 Q4	$450K	Buy	18,775 +5,775	+44%	+$163K	0.17%	90
2018 Q3	$435K	Buy	13,000 +4,100	+46%	+$130K	0.15%	91
2018 Q2	$259K	Buy	8,900 +450	+5%	+$12.5K	0.09%	121
2018 Q1	$218K	Buy	+8,450	New	+$229K	0.08%	129

Other funds holding ARKG

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

CFIM

Client First Investment Management West Bend, Wisconsin $237M AUM 90.28% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

GVCM

Global View Capital Management Waukesha, Wisconsin $484M AUM 48.46% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

PRTG

Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Cambridge Advisors's ARKG Position: Q2 2026 in Review

Cambridge Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 35% in Q2 2026, buying an estimated $105K and bringing the position to 12,576 shares worth $529K. The position accounts for 0.09% of the portfolio, ranked #122.

Cambridge Advisors first reported a position in ARKG in Q1 2018 and has held it in 20 quarters since. The position peaked at $2.08M in Q2 2021. 61 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Cambridge Advisors held 12,576 shares of ARK Genomic Revolution ETF worth $529K as of Q2 2026.
Cambridge Advisors bought 3,283 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $105K.
ARK Genomic Revolution ETF made up 0.09% of Cambridge Advisors's portfolio in Q2 2026, its #122 holding.
Cambridge Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 20 quarters since.
Cambridge Advisors's ARK Genomic Revolution ETF position peaked at $2.08M in Q2 2021.
61 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Cambridge Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.